Skip to main content
GENETIC TECHNOLOGIES LIMITED logo

GENETIC TECHNOLOGIES LIMITED — Investor Relations & Filings

Ticker · GTG ISIN · AU000000GTG7 LEI · 529900YYKY7FRC90M744 ASX Human health and social work activities
Open in API
Filings indexed 1,303 across all filing types
Latest filing 2008-12-30 Annual Report
Country AU Australia
Listing ASX GTG

About GENETIC TECHNOLOGIES LIMITED

https://gtglabs.com/

Genetic Technologies Limited is a molecular diagnostics company focused on the development and commercialization of predictive genetic risk assessment tools. The company specializes in the geneType platform, which integrates clinical risk factors with polygenic risk scores to provide comprehensive risk assessments for various chronic diseases. Its portfolio includes tests for breast cancer, colorectal cancer, prostate cancer, melanoma, type 2 diabetes, and coronary artery disease. By identifying individuals at high risk of developing these conditions, the company enables healthcare providers to implement personalized screening and preventative health strategies. Genetic Technologies Limited serves clinicians and patients globally, aiming to improve health outcomes through early detection and precision medicine.

Recent filings

Filing Released Lang Actions
2008 US Annual Report on Form 20-F 209 pages ?Kb
Annual Report Classification · 100% confidence The document is titled '2008 US Annual Report on Form 20-F' and references filing with the U.S. Securities and Exchange Commission (SEC) for the fiscal year ended June 30, 2008. The Form 20-F is a well-known annual report form used by foreign private issuers to report their annual financial performance to the SEC. The document includes a detailed table of contents with sections typical of an annual report, such as business overview, financial data, risk factors, directors and management, and financial statements. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. Therefore, this document is classified as an Annual Report (10-K equivalent for foreign issuers). FY 2008
2008-12-30 English
Granting of license 1 page ?Kb
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated December 22, 2008, regarding the granting of a license by Genetic Technologies Limited to TIB MOLBIOL. It discusses the licensing program and receipt of payment under a Settlement and License Agreement. The document is short (1916 characters) and is an announcement of a commercial licensing transaction, not a financial report, management discussion, or regulatory filing. It does not contain financial statements, earnings data, or detailed management commentary. It is not a report publication announcement since it does not mention any report being attached or published. The content fits best under Capital/Financing Update (CAP) as it relates to licensing revenue and commercial agreements impacting company capital or revenue streams.
2008-12-21 English
Final Director`s Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Z Final Director’s Interest Notice' and references ASX listing rule 3.19A.3 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including shareholdings and interests in contracts. The document is a formal notification of a director's personal share transactions and holdings, specifically related to a director ceasing to be a director. The content aligns with reporting of insider trades or director dealings rather than financial results, management changes, or other report types. The document length is short and focused solely on director interests, fitting the definition of Director's Dealing (DIRS).
2008-12-15 English
Trading Halt 1 page ?Kb
Regulatory Filings
2008-12-11 English
Request for Trading Halt 1 page ?Kb
Regulatory Filings
2008-12-11 English
Resignation of Director 1 page ?Kb
Board/Management Information Classification · 100% confidence The document is an ASX announcement dated December 12, 2008, regarding the resignation of a director, Dr. Mervyn Jacobson, from Genetic Technologies Limited. It mentions the immediate effect of the resignation and the company's intention to appoint additional directors. There is no financial data, report, or presentation content. The document clearly relates to a change in the company's board of directors. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on management change, confirming the classification.
2008-12-11 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.